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Abstract
The first total synthesis and structural validation of phosdiecin A was accomplished in 13 steps 
(LLS) through asymmetric iridium-catalyzed alcohol-mediated carbonyl reductive coupling. The 
present route is the shortest among >30 total and formal syntheses of fostriecin family members.
Graphical Abstract
Fostriecin (CI-920), a metabolite produced by Streptomyces pulveraceus isolated from a 
Brazilian soil sample in 1983,1 is the forerunner to a ever-growing family of phosphorylated 
polyketide natural products that modulate signal transduction pathways in mammalian cells, 
including the regulation of tumor microenvironment functions that support tumor 
development and protect cancer cells from chemotherapeutic stress.2 These properties are 
linked to their protein phosphatase inhibitory action, in particular, the serine/threonine 
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phosphatases PP1 and PP2A, which display functional roles that include cell cycle 
regulation (PP1 and PP2A), RNA splicing (PP1), cell differentiation (PP2A), apoptosis 
(PP2A), among others.2 Phase I clinical trials were launched for fostriecin but were halted 
before the maximum tolerated dose was established, as its instability and unpredictable 
purity limited supply.3 In 1992, Ohkuma and coworkers reported the isolation of a 
metabolite, dubbed sultriecin, from S. roseiscleroticus No. L827–7 from an Indian soil 
sample bearing a related hydroxylated dihydropyranone and a (Z,Z,E)-triene linked by an 
anti-1,3-diol tether, which was proposed to incorporate a sulfate moiety at C-9.4 In 2010, 
Boger and coworkers reassigned the structure as the C-9 sodium phosphate monoester and 
established its relative and absolute configuration, renaming it phostriecin.5 Like fostriecin, 
phostriecin has garnered interest as a potential chemotherapeutic agent due to its potent and 
selective inhibition of protein phosphatase 2A (PP2A).2,5 More recently, Thomasi and 
coworkers isolated two new phosphorylated polyketides, phosdiecins A and B, from the 
fermentation broth of Streptomyces sp. SS99BA-2 collected on the Brazilian coast.6 The 
structural assignment of phosdiecins A and B (including absolute stereochemistry) has not 
been corroborated by total synthesis and the biological properties of these compounds 
remain unexplored.
The prospect of developing chemotherapeutic agents based on serine/threonine protein 
phosphatase inhibition has driven efforts toward the de novo chemical synthesis of fostriecin 
and related phosphorylated polyketide natural products (Figure 1).7 To date, over 30 total 
and formal syntheses of “fostriecin family” members have been reported.7 The reported 
syntheses of these compounds range between 17–47 steps (LLS) in length. While their 
complexity is variable and earlier syntheses emphasized structure elucidation, it is clear that 
the challenges posed by this compound class are not fully resolved. Recently, one of the 
present authors developed a set of carbonyl reductive couplings and related hydrogen auto-
transfer processes that directly convert lower alcohols to higher alcohols.8 The redox-
economy of these processes has been shown to contribute to increased efficiency in 
polyketide construction.9 Given the longstanding challenges posed by the synthesis of the 
fostriecin family of natural products, and to further benchmark the utility of our catalytic 
methods, a campaign toward phosdiecin A was undertaken. Here, we disclose a 13 step 
(LLS) total synthesis of phosdiecin A - the shortest among >30 syntheses of fostriecin 
family members.
Due to uncertainty regarding the structural assignment of phosdiecins A and B, as a prelude 
to our experimental work DP4+ calculations were undertaken to assess the veracity of the 
proposed structure (see Supporting Information).10 In particular, the assignment of relative 
stereochemistry between the pyran C4–C5 stereotriad with respect to the C9–C11 stereotriad 
was ambiguous. The computational work validates the relative configuration proposed by 
Thomasi and coworkers, which emerged from these studies as the most probable 
stereoisomer. Retrosynthetically, phosdiecin A was envisioned to arise through the 
convergent assembly of Fragments A, B and C (Figure 2). Fragment A was anticipated to be 
accessible through the Sharpless asymmetric epoxidation (SAE)-kinetic resolution (KR)11 of 
furfural adduct 2 (via Achmatowicz reaction) followed by iridium-catalyzed internal redox 
isomerization.12 Fragment B shows higher complexity due to the C9–C11 stereotriad.13 For 
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this fragment, successive use of the present authors carbonyl reductive coupling 
methodology was employed.14,15 Specifically, crotylation of the acetylenic aldehyde 614 
followed by allylation of the β,γ-stereogenic alcohol 915 was planned. Cross-metathesis of 
Fragments A and B, and Suzuki cross-coupling of the resulting vinyl bromide 10 with 
Fragment C would deliver phosdiecin A. Realization of this concise, convergent approach 
could serve as a prelude to the synthesis of other fostriecin family members, as well as the 
design of synthetic analogues for structure-activity studies.
Preparation of Fragment A begins with addition of vinyl magnesium bromide to furfural 1 
(Scheme 1). The resulting allylic alcohol 2 was subjected to conditions for SAE-KR11 to 
provide the lactol 3 in 41% yield, 3:1 dr and 92% ee. Next, to install the C4–C5 syn-diol, an 
iridium-catalyzed dynamic kinetic internal redox isomerization was performed.12 Lactone 4 
was obtained in 36% yield as a single stereoisomer (see Supporting Information for 
determination of relative and absolute stereochemistry). Protection of the secondary alcohol 
as the PMB-derivative delivers Fragment A in a total of four steps (LLS) from furfural 1.
In pursuit of an efficient route to Fragment B, we recently developed the anti-diastereo- and 
enantioselective crotylation of TIPS-protected acetylenic aldehyde 6 through 2-propanol-
mediated reductive coupling of α-methyl allyl acetate catalyzed by the iridium-complex (R)-
Ir-I.14 This reaction was conducted on gram-scale without any erosion in yield or 
stereoselectivity. To convert the homoallylic alcohol 7 to Fragment B, the C11 alcohol was 
transformed to the PMB ether, the acetylenic TIPS moiety was removed and the resulting 
terminal alkyne was treated with NBS to form the acetylenic bromide 8.16 Selective 
ozonolytic cleavage of the terminal alkene17 followed by diimide reduction18 delivered the 
vinyl bromide 9. Finally, direct iridium-catalyzed allylation of the alcohol 9,15 which 
bypasses discrete generation of the configurationally labile chiral α-stereogenic aldehyde, 
provide Fragment B (see Supporting Information for determination of relative and absolute 
stereochemistry). Here, catalyst-directed diastereoselectivity is amplified by Felkin-Anh 
selectivity,19 guiding assembly of the C9–C11 stereotriad with high levels of control 
(Scheme 2).
With Fragments A and B in hand, a challenging cross-metathesis was attempted (Scheme 3). 
This process required extensive experimentation, as the vinyl bromide moiety poses issues 
of functional group compatibility.20 Additionally, the vinyl-substituted pyrans are prone to 
competing olefin isomerization.21 Ultimately, optimal reaction conditions employing Grubbs 
2nd generation catalyst afforded vinyl bromide 10 in 31% yield. Suzuki-Miyaura cross-
coupling with Fragment C22 was conducted using McDonald’s protocol.23 The reaction 
byproducts were most easily removed by subjecting the crude (Z,Z)-diene 11 to 1H-
tetrazole-promoted phosphorylation conditions using diallyl N,N-
diisopropylphosphoramidite followed by peroxide-mediated oxidation to provide the 
protected phosphate ester 12 in 56% yield over the two steps.24 Removal of the PMB 
protecting group followed by palladium-catalyzed allylic reductive cleavage of the diallyl 
phosphate ester 1225 provided (+)-phosdiecin A as the sodium salt. A work up procedure 
involving treatment with Dowex-50 provided the protonated material. The spectral data (1H 
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and 13C NMR) were virtually identical to natural phosdiecin A (see Supporting 
Information).
In summary, the first total synthesis of phosdiecin A was accomplished in 13 steps (LLS) 
through asymmetric iridium-catalyzed alcohol-mediated carbonyl reductive coupling. In >30 
total and formal syntheses of structurally related natural products, 17–47 steps (LLS) were 
required. This work validates the initial structure proposed by Thomasi for this natural 
product.6 Most importantly, the methods and strategies utilized in the present synthesis 
should be transferrable to other fostriecin family members and functional analogues. Studies 
toward this end are in progress and will be reported in due course.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Total synthesis of fostriecin and related phosphorylated polyketide natural products. LLS = 
Longest linear sequence. See Supporting Information and ref. 7 for literature references 
pertaining to the syntheses of the indicated compounds, graphical summaries of their 
syntheses and a detailed inventory of step count.
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Retrosynthetic analysis of phosdiecin A.
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Preparation of Fragment A.a
aYields are of material isolated by silica gel chromatography. Diastereoselectivities were 
determined by 1H NMR of crude reaction mixtures. Enantioselectivities were determined by 
chiral stationary phase HPLC analysis. See Supporting Information for experimental details.
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Preparation of Fragment B.a
aAs described in Scheme 1. See Supporting Information for experimental details.
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Union of Fragments A, B and C and total synthesis of phosdiecin A.a
aYields are of material isolated by silica gel chromatography. See Supporting Information 
for experimental details.
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